Global Antibiotics Market

$3,000.00$7,500.00

  • Type: Common Disease Area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 1046

  • Format: PPT, PDF

Global Antibiotics Market: Segmented by Drug class (Cephalosporin, Penicillin, Fluoroquinolone, Macrolide, Carbapenem, Aminoglycoside, Sulphonamide) by Action Mechanism, by Route of Administration (Oral, Parenteral, Topical, Others), By End Users (Hospitals, Homecare, Specialty Clinics, Others), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America) – Growth, Trends, and Forecasts (2019 – 2028).

Clear

Report Overview

The global antibiotics market size was valued at USD 35.7 billion in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 4.5% from 20 to 2028.

The rising prevalence of infectious diseases and supportive government legislation are the major drivers of the market. Moreover, an increase in antibiotic resistance infections due to misuse or overuse of antibiotics is expected to shift the prescription patterns to novel therapies to treat bacterial infection. According to the CDC, the incidence of antibiotic-resistant infections is more than 2.8 million in the U.S. The pathogens such as Enterobacteriaceae, P. aeruginosa, and K. pneumoniae have a high resistance rate of an average of 40% in developed countries.

Market Drivers

Increasing number of patients suffering from infectious diseases drives the growth of antibiotics market. Ongoing clinical trials are being conducted by many pharmaceuticals’ companies will also boost up the antibiotics market growth. In addition, advances in antibiotics drugs and novel combination therapies to treat antibiotic-resistant microbial infections can advance the treatment landscape can also be a factor that drive the growth this market in the above forecasted period. Furthermore, a special designation from the regulatory authority to various potential pharmaceuticals companies is one of the factors which are expected to drive the market growth.

The rising threat of drug resistance and a weak pipeline of new molecules are leading to the development of combinational formulations. For instance, in countries, like India, the emergence of multi-drug-resistant tuberculosis (TB) is a major factor driving the R&D expenditures. Methicillin-resistant Staphylococcus aureus (MRSA) is another bacterium responsible for several infections in humans that are difficult to treat. The MRSA infection is difficult to treat with standard antibiotics, such as penicillin’s (methicillin, dicloxacillin, nafcillin, and oxacillin), and the cephalosporins. In 2014, the US Food and Drug Administration (FDA) approved four new antibiotics for the treatment of infections caused by gram-positive bacteria, including MRSA.

1. Global Antibiotics Market Overview……………………………………………………….
A. Market Size
2. Market Growth Drivers………………………………………………………………….
A. Rising Prevalence of Infectious Disease and supportive government legislation
B. Emergence of Anti- MRSA/VRE Drugs
C. Vulnerable Aging Population
3. Regulatory and Political Forces…………………………………………………………………
4. Antibiotics Market Segmentation…………………………………………………………..
A. Drug
I. Cephalosporin
II. Penicillin
III. Fluoroquinolone
IV. Macrolide
V. Carbapenem
VI. Sulphonamide
VII. Aminoglycoside
B. Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle-East and Africa Market Analysis
V. South America Market Analysis
5. Antibiotics Products Market Share…………………………………………………..
A. Key Findings
B. Market Analysis, Insights and Forecast – By End user Type
6. Competitive Landscape…………………………………………………………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. Glaxo smith K line PLC Company overview, Product & Services, Strategies & Financials
B. Johnson & Johnson Company overview, Product & Services, Strategies & Financials
C. Pfizer Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………
A. New Trends and Development of Antibiotics market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug:

Penicillin accounted for the largest share of 21.9% in 2019 and is expected to dominate the market over the forecast period due to maximum prescription and the largest number of generic manufacturers in the space. These drugs form the first line of choice in treating infections, such as pharyngitis, skin infections, bronchitis, gonorrhoea, and ear infections. Cephalosporin emerged as the second-largest drug class segment after Penicillin and is expected to grow at a significant rate during the forecast period.

The cephalosporin and fluoroquinolone segments are expected to grow at a significant rate from 2019 to 2028. The growth of these segments can be attributed to the commercialization of new drugs during the forecast period. Currently, there are three cephalosporin drugs in the third phase of clinical trials and are anticipated to commercialize in the next 3 to 4 years. Moreover, the U.S. FDA approval of Shionogi’s Fetroja (cefiderocol) in November 2019 is expected to increase the market share. Similarly, the approval of Lasvic (lascufloxacin) by Japan PMDA and the new drug application submission by Wockhardt Ltd. in India is going to propel the growth of the fluoroquinolone segment.

By Region:

Asia Pacific held the largest share of 40.2% in 2019 and is expected to register a significant growth rate over the forecast period. This can be attributed to the high consumption of antibiotics, increase in the prevalence of infectious diseases, and rising government initiatives to develop novel therapies to treat drug-resistant infections. Moreover, the presence of generic players is contributing to the growth of the regional market. India and China are the biggest markets for antibiotics in the region. Unregulated sales and excessive consumption of antibiotics are the key factors supporting the market growth in these nations.

North America emerged as the second-largest regional market for antibiotics in 2019, followed by Europe. North America and Europe collectively held more than 43.0% share in 2019. These markets are highly regulated with well-developed healthcare infrastructure. The rising incidence of infectious diseases and growing healthcare expenditure by the government are among the key factors driving the North American market. The U.S. government is undertaking various measures, including antibiotic stewardship initiatives and promoting the R&D activities of innovative therapies to control infectious diseases.

Top 5 Major Players

The antibiotics market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies is increasing their market presence, by introducing new products with less prices. Companies, like GlaxoSmithKline, Pfizer PLC, Bayer AG, Novartis AG, and Abbott Inc., hold significant market shares in the antibiotics market.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements